Results 211 to 220 of about 1,140,023 (299)

Chimeric Antigen Receptor T‐Cell Therapy: More Than an Anti‐Cancer Drug

open access: yesHLA, Volume 107, Issue 1, January 2026.
ABSTRACT Initially, chimeric antigen receptor (CAR) T‐cell therapy was developed to eliminate malignant B cells in haematological B‐cell malignancies by targeting CD19 and B‐cell maturation antigen. This approach achieved notable success, resulting in (malignant) B‐cell depletion and inducing clinical remission in cancer patients.
Hannah C. M. Schenk   +8 more
wiley   +1 more source

Safety, Feasibility, and Preliminary Efficacy of Allogeneic MSCs to Treat Advanced Femoral Head Osteonecrosis (ALOFEM): A Pilot Study in Young Onco‐Hematological Patients

open access: yesStem Cells International, Volume 2026, Issue 1, 2026.
Background Severe osteonecrosis of the femoral head (ONFH) secondary to corticosteroid therapy in symptomatic, hematological young patients currently has no therapeutic alternative, and early total hip replacement (THR) is a high‐risk intervention in those patients.
Enrique Gómez-Barrena   +12 more
wiley   +1 more source

Tissue-Resident Myeloid and Histiocytic Cells in Health and Disease: Novel Emerging Concepts. [PDF]

open access: yesAm J Hematol
Valent P   +27 more
europepmc   +1 more source

Targeting the Spleen as an Alternative Site for Hematopoiesis [PDF]

open access: yes, 2019
Lim, Hong   +3 more
core   +1 more source

Unveiling the phenotypic impact of cryopreservation on adipose derived stem cells: A systematic review. [PDF]

open access: yesIndian J Med Res
Farhana S   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy